Evidence supporting the use of: Palmitoylethanolamide (PEA)
For the health condition: Nerve Damage

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Synopsis

Source of validity: Scientific
Rating (out of 5): 3

Palmitoylethanolamide (PEA) and Nerve Damage: Evidence Overview

Palmitoylethanolamide (PEA) is an endogenous fatty acid amide that has garnered attention for its potential neuroprotective and analgesic properties. Its use in supporting or treating nerve damage—particularly neuropathic pain—has a basis in scientific research rather than tradition.

Several clinical studies and meta-analyses have explored the efficacy of PEA in reducing neuropathic pain, which is often a consequence of nerve damage. PEA is thought to exert its effects primarily through modulation of mast cells and glial cells, as well as influencing the endocannabinoid system, which plays a role in inflammation and pain signaling. These mechanisms may help reduce neuroinflammation and alleviate pain symptoms in conditions such as diabetic neuropathy, sciatic pain, and post-herpetic neuralgia.

Randomized controlled trials and open-label studies have shown that PEA supplementation, usually in micronized or ultra-micronized forms, can lead to significant reductions in pain scores compared to baseline and sometimes compared to placebo. However, the quality of evidence varies, with some studies limited by small sample sizes, short duration, or lack of blinding.

In summary, while there is moderate scientific evidence (rated 3/5) supporting PEA’s use for nerve damage-related pain, larger and more rigorous clinical trials are needed to confirm its efficacy and establish optimal dosing regimens. Nevertheless, current data suggest that PEA may be a promising adjunct for managing neuropathic pain due to nerve damage.

More about Palmitoylethanolamide (PEA)
More about Nerve Damage

Products containing Palmitoylethanolamide (PEA)

We currently have no products on Vitabase that contain this ingredient.